Results 91 to 100 of about 3,955 (172)

Anti-tumor activities of CIK cells derived from lymph nodes of lung cancer patients

Zhongguo aizheng zazhi, 2015
Background and purpose: Cytokine-induced killer (CIK) has both the advantages of T lymphocytes’ powerful anti-tumor activity and NK cells’ tumor killing capacity without MHC restriction.
滕家俊, 周　严, 刘显勋
doaj  

Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application

Human Vaccines & Immunotherapeutics, 2017
Cell-based immunotherapy holds promise in the quest for the treatment of cancer, having potential synergy with surgery, chemotherapy and radiotherapy.
Yiming Meng, Zhifu Yu, Yefeng Wu, Tianzhao Du, Shi Chen, Fanjuan Meng, Nan Su, Yushu Ma, Xiaoxi Li, Sulan Sun, Guirong Zhang   +10 more
doaj   +1 more source

Cytokine-induced killer cells: new insights for therapy of hematologic malignancies

Stem Cell Research & Therapy
Background Cytokine-induced killer (CIK) cells are a novel subgroup of immune effectors, classified as one of the modified T cell-mediated arms for immunotherapy.
Faezeh Ghanbari Sevari, Amir Mehdizadeh, Khadijeh Abbasi, Seyyed Sina Hejazian, Mortaza Raeisi   +4 more
doaj   +1 more source

Strategi Cik Uniang Cik Ajo Duta Wisata Dalam Rangka Transformasi Promosi Pariwisata di Kota Pariaman

Jurnal ISO: Jurnal Ilmu Sosial, Politik dan Humaniora
Tujuan dari penelitian ini adalah untuk mengkaji pelaksanaan transformasi promosi pariwisata di kota Pariaman yang dilakukan oleh Cik Uniang Cik Ajo duta wisata dengan menganalisis strategi serta menetapkan strategi yang tepat. Latar belakang penelitian ini adalah belum optimalnya kegiatan promosi pariwisata yang dilakukan oleh Cik Uniang Cik Ajo duta ...
Lidiya Wahyuni, Aldri Frinaldi
openaire   +1 more source

Synergistic integration of histone deacetylase inhibitors apparently enhances the cytokine‐induced killer cell efficiency in multiple myeloma via the NKG2D pathway

Clinical & Translational Immunology
Objectives The rapid recognition of epigenetic manipulation's potential in restricting cancer cell capabilities spurred translational initiatives, including histone deacetylase inhibitors (HDACis).
Jingjing Pu, Amit Sharma, Ting Liu, Jian Hou, Ingo GH Schmidt‐Wolf   +4 more
doaj   +1 more source

Dr-CiK: A Testbed for Foresight-Driven Agents

Time series forecasting in real-world settings often depends not only on historical observations, but also on external context that must be actively discovered from noisy, heterogeneous information sources. Yet existing context-aided forecasting benchmarks typically assume that the supporting context is already provided, leaving open whether agents can
Tang, Yihong, Williams, Andrew Robert, Ashok, Arjun, Zheng, Vincent Zhihao, Sun, Lijun, Drouin, Alexandre, Laradji, Issam H., Marcotte, Étienne, Zantedeschi, Valentina   +8 more
openaire   +2 more sources

CIK细胞治疗对鼻咽癌患者肿瘤标志物及生活质量的影响

Zhongshan Daxue xuebao. Yixue kexue ban, 2011
【目的】观察鼻咽癌患者回输自体CIK细胞后临床症状缓解情况及EB病毒指标变化【方法】 收集鼻咽癌病例42例,其中放化疗联合CIK组21例进行CIK生物治疗(参照美国斯坦福大学骨髓移植中心建立的 CIK细胞培养方法诱导扩增 CIK细胞, CIK细胞培养 14 d后分次回输给患者)及进行放疗或/和化疗,放化疗组21例仅进行放疗或/和化疗【结果】随访6 ~ 27个月,中位随访时间14.5个月,放化疗联合CIK组食欲明显改善,并且其肿瘤标志物(VCA-IgAEA-IgAEA-IgG及EBV-DNA ...
doaj  

Safety and efficacy of cytokine-induced killer cells for gastric cancer: a systematic review and meta-analysis. [PDF]

Front Oncol
Zhu M, Yang C, Liang B, Liu Q.
europepmc   +1 more source

An Exploratory in vitro Study of Cytotoxicity and Cytokine Profiling of Cytokine-Induced Killer (CIK) Cells Against HCT-15 Colorectal Cancer (CRC) Cells. [PDF]

Immunotargets Ther
Chin SP, Nor Arfuzir NN, Kong VW, Cheong SK.   +3 more
europepmc   +1 more source

First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia. [PDF]

J Clin Oncol
Rettinger E, Heckl D, Hutter M, Salzmann-Manrique E, Luedtke M, Huenecke S, Bremm M, Cappel C, Bug G, Greil J, Meisel R, Wagner-Drouet EM, Serve H, Güngör T, Klusmann JH, Klingebiel T, Bader P, Bonig H.   +17 more
europepmc   +1 more source